Wegovy and Zepbound are the two heavyweight names in prescription weight loss, and people comparing them want a clear answer: which one takes off more weight? Thanks to a direct head-to-head trial, that question finally has an evidence-based reply, though the "better" choice still depends on you.
Quick Answer
Wegovy and Zepbound are different drugs. Wegovy is semaglutide; Zepbound is tirzepatide. In the only large head-to-head trial, Zepbound produced more weight loss, about 20% of body weight on average versus about 14% for Wegovy over 72 weeks. Zepbound acts on two gut hormone receptors instead of one, which appears to explain the edge. Both are once-weekly injections with similar, mostly digestive side effects. The right pick depends on your goals, tolerance, cost, and access.
Is Zepbound and Wegovy the Same Thing?
No. They are different medications with different active ingredients.
- Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a single gut hormone.
- Zepbound contains tirzepatide, a dual agonist that activates two receptors, GLP-1 and GIP.
Both are once-weekly subcutaneous injections approved for chronic weight management, and both are titrated up slowly. But because they are different molecules acting on different numbers of receptors, they are not interchangeable.
Is Zepbound or Wegovy Better for Weight Loss?
On total weight lost, the trial evidence favors Zepbound. In SURMOUNT-5, a 72-week head-to-head trial in adults with obesity without diabetes, the results were:
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →- Zepbound (tirzepatide): about 20.2% average body weight reduction
- Wegovy (semaglutide): about 13.7% average body weight reduction
That is a meaningful gap, and it lines up with tirzepatide's dual mechanism. Hitting two hormone pathways appears to amplify appetite and metabolic effects beyond what a single-pathway drug achieves.
That said, "better" is not only the scale number. Wegovy has a longer real-world track record and carries an FDA approval to reduce cardiovascular risk in adults with established cardiovascular disease and obesity or overweight. If you respond well to Wegovy and tolerate it, more potency is not automatically the right trade.
Wegovy vs Zepbound Comparison Table
| Feature | Wegovy | Zepbound |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Drug class | GLP-1 receptor agonist | Dual GIP and GLP-1 agonist |
| Receptors targeted | One | Two |
| Administration | Once-weekly injection | Once-weekly injection |
| Avg weight loss (head-to-head) | About 13.7% over 72 weeks | About 20.2% over 72 weeks |
| Extra approval | Cardiovascular risk reduction | Obstructive sleep apnea with obesity |
| Common side effects | Nausea, diarrhea, constipation | Nausea, diarrhea, constipation |
Does Zepbound Have Fewer Side Effects Than Wegovy?
The side-effect profiles are similar. Both are dominated by gastrointestinal symptoms: nausea, diarrhea, constipation, and reduced appetite, usually worst during dose increases and easing over time. Neither is clearly gentler across the board, and individual tolerance varies. Some people handle one better than the other. Slow titration, smaller meals, hydration, and a protein-forward diet help with tolerance on either drug.
Is Wegovy Cheaper Than Zepbound?
Pricing for both is high without coverage and varies by pharmacy, insurance, savings programs, and over time. Cost is frequently the deciding factor in practice, so it is worth checking current prices and coverage for each rather than assuming one is always cheaper.
Which Should You Choose?
- Lean Zepbound if maximizing weight loss is the priority and you tolerate it.
- Lean Wegovy if you value its longer track record and cardiovascular approval, or if you respond well to it.
- Let cost and access decide when the clinical differences are not decisive for you.
- Discuss with a clinician, who will weigh your full health picture.
Frequently Asked Questions
Is Zepbound and Wegovy the same thing? No. Wegovy is semaglutide and Zepbound is tirzepatide. They are different molecules and are not interchangeable.
Is Zepbound or Wegovy better for weight loss? In the head-to-head trial, Zepbound produced more weight loss, about 20% versus about 14%. "Better" still depends on goals, tolerance, and cost.
Does Zepbound or Wegovy work better? On the scale, Zepbound showed greater average weight loss in the direct comparison trial.
Does Zepbound have fewer side effects than Wegovy? The profiles are similar, dominated by GI symptoms. Neither is clearly gentler, and tolerance varies by person.
Is Wegovy cheaper than Zepbound? It varies by pharmacy, insurance, and savings programs. Compare current prices and coverage for each.
Is Wegovy safer than Zepbound? Both have similar safety profiles and warnings. Neither is suitable for everyone, and eligibility is set by a clinician.
Can I switch from Wegovy to Zepbound? Many people do, often seeking more weight loss. A switch should be clinician-guided, with titration restarted to manage side effects.
Will I regain weight if I stop either one? Weight regain is common after stopping either if lifestyle changes are not maintained, because the appetite effect ends with the drug.
If you are comparing treatment paths, FormBlends offers access to compounded semaglutide and a provider comparison tool.
Sources
- New England Journal of Medicine, Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5): https://www.nejm.org/doi/full/10.1056/NEJMoa2416394
- FDA prescribing information for tirzepatide (Zepbound): https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →
